4R tau RT-QuIC has also been developed, and yielded promising data from postmortem CSF in which 4/4 CBD and 7/7 PSP cases were positive (≥50% of the replicate reactions above the fluorescence threshold) and 2/2 controls tested negative (Saijo et al., 2020). Here, MAPT is linked to supranuclear palsy, progressive, 1.